fusidic acid has been researched along with tobramycin in 13 studies
Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (tobramycin) | Trials (tobramycin) | Recent Studies (post-2010) (tobramycin) |
---|---|---|---|---|---|
1,742 | 117 | 344 | 4,902 | 629 | 1,205 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 7 (53.85) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
Adenis, JP; Robert, PY | 1 |
Dattani, D; Jackson, WB; Leeder, RG; Low, DE; MacDougall, R; Whitsitt, PF | 1 |
Li, R; Liu, C; Sun, XG; Wang, ZQ | 1 |
Appelbaum, PC; Beachel, L; Clark, C; Credito, K; Kosowska-Shick, K; McGhee, P; Pankuch, GA | 1 |
Abdiche, G; Batellier, L; Borsali, E; Chaumeil, C; Gleize, D; Goldschmdt, P; Laroche, L; Le Bouter, A; Legrand, P | 1 |
Chen, PW; Dai, HF; Huang, XL; Kong, FD; Luo, DQ; Ma, QY; Wang, P; Xie, QY; Yuan, JZ; Zhao, YX; Zhou, LM | 1 |
1 review(s) available for fusidic acid and tobramycin
Article | Year |
---|---|
Comparative review of topical ophthalmic antibacterial preparations.
Topics: Administration, Topical; Anti-Bacterial Agents; Chloramphenicol; Eye Infections, Bacterial; Fusidic Acid; Gentamicins; Humans; Quinolones; Tobramycin; Trachoma | 2001 |
1 trial(s) available for fusidic acid and tobramycin
Article | Year |
---|---|
Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Conjunctivitis, Bacterial; Female; Fusidic Acid; Humans; Male; Middle Aged; Ophthalmic Solutions; Patient Compliance; Patient Satisfaction; Single-Blind Method; Tobramycin | 2002 |
11 other study(ies) available for fusidic acid and tobramycin
Article | Year |
---|---|
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
[Analysis on the susceptibility of fusidic acid for common gram positive bacteria].
Topics: Anti-Bacterial Agents; Fusidic Acid; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus; Tobramycin; Vancomycin | 2009 |
In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.
Topics: Amikacin; Burkholderia cepacia; Cystic Fibrosis; Drug Synergism; Fusidic Acid; Humans; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 2011 |
[Ornithinimicrobium pekingense ocular infection].
Topics: Actinomycetales; Actinomycetales Infections; Aged; Cataract; Ciprofloxacin; Corneal Edema; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Female; Fusidic Acid; Humans; Keratoplasty, Penetrating; Ointments; Ophthalmic Solutions; Postoperative Complications; Rifamycins; Tobramycin | 2011 |
Helvolic Acid Derivatives with Antibacterial Activities against Streptococcus agalactiae from the Marine-Derived Fungus Aspergillus fumigatus HNMF0047.
Topics: Anti-Bacterial Agents; Aspergillus fumigatus; Circular Dichroism; Fusidic Acid; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Streptococcus agalactiae; Tobramycin | 2018 |